These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer. Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680 [TBL] [Abstract][Full Text] [Related]
6. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599 [TBL] [Abstract][Full Text] [Related]
7. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pathological node status after neoadjuvant radiotherapy for rectal cancer. Duchalais E; Glyn Mullaney T; Spears GM; Kelley SR; Mathis K; Harmsen WS; Larson DW Br J Surg; 2018 Oct; 105(11):1501-1509. PubMed ID: 29663352 [TBL] [Abstract][Full Text] [Related]
9. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer. Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192 [TBL] [Abstract][Full Text] [Related]
10. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088 [TBL] [Abstract][Full Text] [Related]
11. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer. Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983 [TBL] [Abstract][Full Text] [Related]
12. What To Do With Lateral Nodal Disease in Low Locally Advanced Rectal Cancer? A Call for Further Reflection and Research. Kusters M; Slater A; Muirhead R; Hompes R; Guy RJ; Jones OM; George BD; Lindsey I; Mortensen NJ; Cunningham C Dis Colon Rectum; 2017 Jun; 60(6):577-585. PubMed ID: 28481851 [TBL] [Abstract][Full Text] [Related]
13. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?]. Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241 [TBL] [Abstract][Full Text] [Related]
14. Impact of residual nodal involvement after complete tumor response in patients undergoing neoadjuvant (chemo)radiotherapy for rectal cancer. Erkan A; Mendez A; Trepanier M; Kelly J; Nassif G; Albert MR; Lee L; Monson JRT Surgery; 2019 Oct; 166(4):648-654. PubMed ID: 31378480 [TBL] [Abstract][Full Text] [Related]
15. Organ Preservation Among Patients With Clinically Node-Positive Rectal Cancer: Is It Really More Dangerous? Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; Ortega CD; Figueiredo N; Gama-Rodrigues J; Perez RO Dis Colon Rectum; 2019 Jun; 62(6):675-683. PubMed ID: 30870223 [TBL] [Abstract][Full Text] [Related]
16. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Smith FM; Wiland H; Mace A; Pai RK; Kalady MF Dis Colon Rectum; 2014 Mar; 57(3):311-5. PubMed ID: 24509452 [TBL] [Abstract][Full Text] [Related]
17. Lymph Node Yield After Neoadjuvant Chemoradiotherapy in Rectal Cancer Specimens: A Randomized Trial Comparing Two Fixatives. Dias AR; Pereira MA; de Mello ES; Nahas SC; Cecconello I; Ribeiro U Dis Colon Rectum; 2018 Aug; 61(8):888-896. PubMed ID: 29944580 [TBL] [Abstract][Full Text] [Related]
18. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Habr-Gama A; Sabbaga J; Gama-Rodrigues J; São Julião GP; Proscurshim I; Bailão Aguilar P; Nadalin W; Perez RO Dis Colon Rectum; 2013 Oct; 56(10):1109-17. PubMed ID: 24022527 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response. Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059 [TBL] [Abstract][Full Text] [Related]
20. Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer. Duldulao MP; Lee W; Streja L; Chu P; Li W; Chen Z; Kim J; Garcia-Aguilar J Dis Colon Rectum; 2013 Feb; 56(2):142-9. PubMed ID: 23303141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]